Task: Answer the multiple choice question.
Query: Which drug exhibits a 4.503% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CCOc1cc(C(=O)NC)cc(OCC)c1OCC
b) O=C(CSc1nnc(CNc2ccccc2)o1)N1CCN(C(=O)c2ccco2)CC1
c) COc1cccc(C(=O)OCCN2C(=O)c3ccccc3C2=O)c1OC
Answer: c. COc1cccc(C(=O)OCCN2C(=O)c3ccccc3C2=O)c1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(C(=O)OCCN2C(=O)c3ccccc3C2=O)c1OC
COc1cccc(C(=O)OCCN2C(=O)c3ccccc3C2=O)c1OC
2-(1,3-dioxoisoindol-2-yl)ethyl 2,3-dimethoxybenzoate